Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleusZhenglan Huang, Wenli Feng|Oncotarget|2013Cited by 16
The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplificationDachuan Zeng, Zhenglan Huang|Experimental Hematology and Oncology|2022Cited by 14
Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABLRun Qin, Zhenglan Huang|Cell Communication and Signaling|2023Cited by 12